Interestingly, we also identified lower methylation of cg01550828, associated with gene RNF168 as a biomarker for pathogenesis of intermediate status (precancerous lesions/intraepithelial neoplasia), providing a novel approach for predicting the precancerous lesion stage. This evidence concerns the gene RNF168 and intraepithelial neoplasia.